“This transaction demonstrates the growing appetite in the market for Freddie Mac’s CME platform and DBBM’s expertise in the CME product,” said Jeff Day, co-head of DBBM. “Through collaboration with Freddie Mac, we were able to leverage our relationships and make this a seamless transaction.”